As Taiwan navigates the challenges of a super-aged population, GSK leads with innovative solutions, focusing on prevention and treatment. By uniting science, technology, and talent, the company aims to improve health outcomes for Taiwan and beyond.
With 175 years of history comes a crystal-clear vision of the future: a bold, innovative, and robust generation of leaders raised by Pfizer Taiwan, striving to help one billion lives globally in 2027. This wave of talent is guided by Pfizer’s four core values – Courage, Excellence, Equity, and Joy – delivering world-class growth and…
As cardiometabolic diseases, such as Type 2 diabetes and obesity, continue to rise globally, the healthcare industry faces unprecedented challenges. According to the World Health Organization (WHO), more than one billion people are affected by obesity, an alarming figure that spurred the coining of the term “globesity.” Obesity is not only a significant health issue…
As Taiwan pushes toward a greener future, innovative financial solutions play a crucial role in renewable energy projects. Maiora Renewable Energy, a leader in solar power, emphasizes the importance of long-term feed-in tariffs and stable regulatory frameworks in attracting international investment, while addressing the complexities of local approval processes and grid challenges.
Micron has been integral to Taiwan’s economy for three decades, with an investment of NT$1 trillion and a workforce of over 10,500 employees. As Taiwan’s largest manufacturing site, Micron leads in developing cutting-edge DRAM and HBM technologies essential for the future of AI applications. Committed to sustainability, the company is advancing towards a net-zero carbon goal by 2030, alongside efforts to boost STEM education and support local communities.
At the 2024 U.S.-Taiwan Patient Day Innovation Forum, Shih Chung-liang from NHIA emphasized the benefits of transcatheter aortic valve implantation (TAVI), noting its less invasive nature and faster recovery compared to traditional surgery. As Taiwan’s population ages, the demand for TAVI is expected to rise, with Edwards Lifesciences leading advancements in this transformative technology.
Citi Taiwan celebrates its 60th anniversary in 2024, highlighting six decades of growth and global impact. The bank has been a key player in connecting Taiwan to international markets, excelling in Corporate, Investment, and Commercial Banking, as well as Treasury and Securities Services. Citi has led major M&A deals and earned prestigious awards, reflecting its commitment to innovation and client support. As it looks to the future, Citi remains dedicated to advancing Taiwan’s financial landscape.
Eli Lilly is advancing treatments in oncology, diabetes, immunology, obesity, and Alzheimer’s disease, with new therapies on the horizon. In Taiwan, Lilly is addressing growing concerns about dementia and obesity with significant R&D investment and plans to conduct over 60 clinical trials in 2024.
Electron microscopy is critical in enabling the examination of microchips and nanostructures, which then ensure the integrity and performance of semiconductor devices that power solutions around the world. The demand for high-performance semiconductor technology is growing exponentially, including generative AI, smart devices, and renewable energy. As Taiwan solidifies itself as a leader in the international…
